Codexis FY2024 revenue $59.3M, net loss $65.3M; guides 2025 revenue $64M-$68M

CODEXIS, INC.

2024-FY EPS reported -$0.89 revenue$59,345,000

FY2024 total revenue $59.3M (-4% YoY ex-PAXLOVID); net loss $65.3M ($0.89/share) vs $76.2M ($1.12) in FY2023.
Q4 total revenue $21.5M (+17% YoY ex-PAXLOVID); net loss $10.4M ($0.13/share) vs $7.2M ($0.10) in Q4 2023.
Guides FY2025 total revenue $64M-$68M (double-digit growth); expects path to cash flow positivity by end of 2026.
Cash, cash equivalents and short-term investments $73.5M at Dec 31, 2024; raised $31M via ATM in Sep 2024.
Appointed Arthur Levin to Strategic Advisory Board; expects first ECO Synthesis contract in H1 2025 and GMP scale-up partner by end of 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.